CCL19 and congenital bilateral aplasia of vas deferens from CFTR mutation: Significantly high expression level of CCL19 of SCG2 in CAVD (Figure 5A) and ROC curves in the training datasets revealed their probability as valuable biological markers with AUCs of 0.940 and 0.913, respectively (Figure 5B), indicating a high diagnostic value.